Abstract
Inhibition of DNA repair is one proposed mechanism for the co-mutagenicity/co-carcinogenicity of arsenic. This review summarizes the current literature on the effects of arsenic compounds on nucleotide excision repair (NER). Several possible mechanisms for the observed NER inhibition have been proposed. Modulation of the expression of NER proteins has been considered to be one possibility of impairing the NER process. However, data on the effects of arsenic on the expression of NER proteins remain inconsistent. It is more likely that arsenic inhibits the induction of accessory or other key proteins involved in cellular control of DNA repair pathways, such as p53. For example, arsenic affects p53 phosphorylation and p53 DNA binding activity, which could regulate NER through transcriptional activation of downstream NER genes. Although it is important to study possible direct inactivation of NER proteins by arsenic binding, indirect inactivation of proteins having thiol residues critical to their function or zinc finger proteins cannot be negated. For example, nitric oxide (NO) induced in arsenic-treated cells serves as a specific inhibitor of NER, possibly through NO-induced S-nitrosylation of proteins related to DNA repair. Poly(ADP-ribose) polymerase-1, a zinc finger protein implicated in both NER and base excision repair (BER), deserves special attention because of its involvement in NO production and its broad range of protein substrates including many repair enzymes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tokar E J, Benbrahim-Tallaa L, Ward J M, et al. Cancer in experimental animals exposed to arsenic and arsenic compounds. Crit Rev Toxicol, 2010, 40: 912–927
Wang J P, Qi L, Moore M R, et al. A review of animal models for the study of arsenic carcinogenesis. Toxicol Lett, 2002, 133: 17–31
Pott W A, Benjamin S A, Yang R S. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev Environ Contam Toxicol, 2001, 169: 165–214
Rossman T G. Mechanism of arsenic carcinogenesis: An integrated approach. Mutat Res, 2003, 533: 37–65
Basu A, Mahata J, Gupta S, et al. Genetic toxicology of a paradoxical human carcinogen, arsenic: A review. Mutat Res, 2001, 488: 171–194
Gebel T W. Genotoxicity of arsenical compounds. Int J Hyg Environ Health, 2001, 203: 249–262
Salnikow K, Zhitkovich Z. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcingenesis: Nickel, arsenic, and chromium. Chem Res Toxicol, 2008, 21: 28–44
Tapio S, Grosche B. Arsenic in the aetiology of cancer. Mutat Res, 2006, 612: 215–246
Hoeijmakers J H J. Genome maintenance mechanisms for preventing cancer. Nature, 2001, 411: 366–374
Friedberg E C. How nucleotide excision repair protects against cancer. Nat Rev Cancer, 2001, 1: 22–33
Balajee A S, Bohr V A. Genomic heterogeneity of nucleotide excision repair. Gene, 2000, 250: 15–20
Hartwig A, Schwerdtle T. Interaction by carcinogenic metal compounds with DNA repair processes: Toxicological implications. Toxicol Lett, 2002, 127: 47–54
Hartwig A, Schwerdtle T. Arsenic-induced carcinogenicity: New insights in molecular mechanism. In: Hadjiliadis N, Sletten E, eds. Metal Complex-DNA Interactions. Chichester: John Wiley & Sons, 2009. 491–510
Hughes M F, Beck B D, Chen Y, et al. Arsenic exposure and toxicology: A historical perspective. Toxicol Sci, 2011, 123: 305–332
Rossman T G, Klein C B. Genetic toxicology of arsenic and antimony. In: Sun H, ed. Biological Chemistry of Arsenic, Antimony and Bismuth. Chichester: John Wiley & Sons, 2011. 331–351
Ren X, McHale C M, Skibola C F, et al. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect, 2011, 119: 11–19
Rossman T G, Klein C B. Genetic and epigenetic effects of environmental arsenicals. Metallomics, 2011, 3: 1135–1141
van Hoffen A, Balajee A S, van Zeeland A A, et al. Nucleotide excision repair and its interplay with transcription. Toxicology, 2003, 193: 79–90
Okui T, Fujiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat Res, 1986, 172: 69–76
Snyder R D, Davis G F, Lachmann P J. Inhibition by metals of X-ray and ultraviolet-induced DNA repair in human cells. Biol Trace Element Res, 1989, 21: 389–398
Chao C C-K. Inhibition of arsenite of anticancer drug cis-diam-minedichloroplatinum(II) induced DNA repair and drug resistance in HeLa cells. Environ Toxicol Pharmacol, 1996, 1: 199–205
Hartmann A, Speit G. Effect of arsenic and cadmium on the persistence of mutagen-induced DNA lesions in human cells. Environ Mol Mutagenesis, 1996, 27: 98–104
Wang T C, Huang J S, Yang V C, et al. Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite. Int J Radiat Biol, 1994, 66: 367–372
Ding W, Hudson L G, Sun X, et al. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radic Biol Med, 2008, 45: 1065–1072
Bau D T, Gurr J R, Jan K Y. Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision. Carcinogenesis, 2001, 22: 709–716
Lee-Chen S F, Yu C T, Jan K Y. Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagenesis, 1992, 7: 51–55
Wu F, Burns F J, Zhang R, et al. Arsenite-induced alterations of DNA photodamage repair and apoptosis after solar-simulation UVR in mouse keratinocytes in vitro. Environ Health Perspect, 2005, 113: 983–986
Danaee H, Nelson H H, Liber H, et al. Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis, 2004, 19: 143–148
Hartwig A, Gröblinghoff U D, Beyersmann D, et al. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis, 1997, 18: 399–405
Chiang H C, Tsou T C. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells. Toxic Vitro, 2009, 23: 897–905
Schwerdtle T, Walter I, Hartwig A. Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair, 2003, 2: 1449–1463
Shen S, Lee J, Weinfeld M, et al. Attenuation of DNA damage-induced p53 expression by arsenic: A possible mechanism for arsenic c-carcinogenesis. Mol Carcinog, 2008, 47: 508–518
Shen S. Arsenic effects on the formation and repair of BPDE-DNA adducts. Dissertation for the Doctoral Degree. Edmonton: University of Alberta, 2006
Maier A, Schumann B L, Chang X, et al. Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity. Mutat Res, 2002, 517: 101–111
Tran H P, Prakash A S, Barnard R, et al. Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene. Toxicol Lett, 2002, 133: 59–63
Liu S. Effects of arsenic on DNA repair and cell cycle checkpoints: Involvement in arsenic co-mutagenesis and co-carcinogenesis. Dissertation for the Doctoral Degree. Cincinnati: University of Cincinnati, 2005
Qin X J, Liu W, Li Y N, et al. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci, 2012, 127: 120–129
Lynn S, Shiung J N, Gurr J R, et al. Arsenite stimulates poly (ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med, 1998, 24: 442–449
Ochi T, Ishiguro T, Ohsawa M. Induction of alkaline-labile sites in DNA by benzo(a)pyrene and the repair of those lesions in cultured Chinese hamster cells. Mutat Res, 1986, 165: 31–38
Dong J T, Luo X M. Arsenic-induced DNA strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat Res, 1993, 302: 97–102
Reddy M V. Methods for testing compounds for DNA adduct formation. Regul Toxicol Pharmacol, 2000, 32: 256–263
Phillips D H, Farmer P B, Belandf F A, et al. Methods of DNA adducts determination and their application to testing compounds for genotoxicity. Environ Mol Mutagen, 2000, 35: 222–233
Liu J, Kadiiska M B, Liu Y, et al. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci, 2001, 61: 314–320
Snow E T, Hu Y, Klein C B, et al. Regulation of redox an d DNA repair genes by arsenic: Low dose protection against oxidative stress? In: Chappel W R, Abernathy C O, Calderon R L, et al. eds. Arsenic Exposure and Health Effects V. San Diego: Elsevier, 2003. 305–319
Andrew A S, Karagas M R, Hamilton J W. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer, 2003, 104: 263–268
Andrew A S, Burgess J L, Meza M M, et al. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect, 2006, 114: 1193–1198
Mo J, Xia Y, Wade T J, et al. Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: Assessment by real-time PCR arrays. Int J Environ Res Public Health, 2011, 8: 2090–2108
Mo J, Xia Y, Ning Z, et al. Elevated ERCC1 gene expression in blood cells associated with exposure to arsenic from drinking water in Inner Mongolia. Anticancer Res, 2009, 29: 3253–3260
Hamadeh H K, Trouba K J, Amin R P, et al. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol Sci, 2002, 69: 306–316
Andrew A S, Warren A J, Barchowsky A, et al. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect, 2003, 111: 825–838
Bae D-S, Hanneman W H, Yang R S H, et al. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: Application of cDNA microarray technology. Environ Health Perspect, 2002, 110: 931–941
Wang A, Wolf D C, Sen B, et al. Dimethylarsinic acid in drinking water changed the morphology of urinary bladder but not the expression of DNA repair genes of bladder transitional epithelium in F344 rats. Toxicol Pathol, 2009, 37: 425–437
Nollen M, Ebert F, Moser J, et al. Impact of arsenic on nucleotide excision repair: XPC function, protein level, and gene expression. Mol Nutr Food Res, 2009, 53: 572–582
Muenyi C S, States V A, Masters J H, et al. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC). J Ovarian Res, 2011, 4: 1–11
Jasso-Pineda Y, Diaz-Barriga F, Calderon J, et al. DNA damage and decreased DNA repair in peripheral blood mononuclear cells in individuals exposed to arsenic and lead in a mining site. Biol Trace Elem Res, 2012, 146: 141–149
Lynn S, Lai H T, Gurr J R, et al. Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis, 1997, 12: 353–358
Hu Y, Su L, Snow E T. Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat Res, 1998, 408: 203–218
Asmuss M, Mullenders L H F, Eker A, et al. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis, 2000, 21: 2097–2104
Piatek K, Schwerdtle T, Hartwig A, et al. Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: Mechanistic considerations and consequences for DNA repair inhibition. Chem Res Toxicol, 2008, 21: 600–606
Flohr C, Burkle A, Radicella J P, et al. Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway dependent on Cockayne syndrome B protein. Nucleic Acids Res, 2003, 31: 5332–5337
Zhou X, Cooper K L, Wang F, et al. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J Biol Chem, 2011, 286: 22855–22863
Hartwig A, Pelzer A, Asmuss M, et al. Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells. Int J Cancer, 2003, 104: 1–6
Walter I, Schwerdtle T, Thuy C, et al. Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair, 2007, 6: 61–70
Chang Y C, Jan K Y, Cheng C A, et al. Direct involvement of the tumor suppressor p53 in nucleotide excision repair. DNA Repair, 2008, 7: 751–761
Hwang B J, Ford J M, Hanawalt P C, et al. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA, 1999, 96: 424–428
Adimoolam S, Ford J M. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci USA, 2002, 99: 12985–12990
Rubbi C P, Milner J. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J, 2003, 22: 975–986
Wang X W, Yeh H, Schaeffer L, et al. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet, 1995, 10: 188–195
Wang Q, Zhu Q, Wani A A, et al. Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage. DNA Repair, 2003, 2: 483–499
Fitch M E, Nakajima S, Yasui A, et al. In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product. J Biol Chem, 2003, 278: 46906–46910
Wang Q, Zhu Q, Wani G, et al. UV radiation-induced XPC translocation within chromatin is mediated by damage-DNA binding protein, DDB2. Carcinogenesis, 2004, 25: 1033–1043
Bode A M, Dong Z. The paradox of arsenic: Molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol, 2002, 42: 5–24
Yan W, Zhang Y, Zhang J, et al. Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression. J Biol Chem, 2011, 286: 17478–17486
Tang F, Liu G, He Z, et al. Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells. Mol Carcinog, 2006, 45: 861–870
Vogt B L, Rossman T G. Effects of arsenite on p53, p21 and cyclin D expression nin normal human fibroblasts—A possible mechanism for arsenite’s comutagenicity. Mutat Res, 2001, 478: 159–168
Yager J W, Wiencke J K. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat Res, 1997, 386: 345–351
Hernandez-Zavala A, Cordova E, Del Razo L M, et al. Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology, 2005, 207: 49–57
Hartwig A, Asmuss M, Ehleben I, et al. Interference by toxic metal ions with DNA repair processes and cell cycle control: Molecular mechanisms. Environ Health Perspect, 2002, 110: 797–799
Chien Y H, Bau D T, Jan K Y. Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair. Free Radic Biol Med, 2004, 36: 1011–1017
Davis K L, Martin E, Turko I V, et al. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol, 2001, 41: 203–236
Yu Z, Kuncewicz T, Dubinsky W P, et al. Nitric oxide-dependent negative feedback of PARP-1 transactivation of the inducible nitricoxide synthase gene. J Biol Chem, 2006, 28: 9101–9109
Pleschke J M, Kleczkowska H E, Strohm M, et al. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem, 2000, 29: 40974–40980
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Shen, S., Wang, C., Weinfeld, M. et al. Inhibition of nucleotide excision repair by arsenic. Chin. Sci. Bull. 58, 214–221 (2013). https://doi.org/10.1007/s11434-012-5439-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-012-5439-x